White matter and cognitive function in schizophrenia

International Journal of Neuropsychopharmacology

Volumn 10, Issue 4, 2007, Pages 513-536

  Dwork, Andrew J ^a,b,d   Mancevski, Branislav ^a,b   Rosoklija, Gorazd ^a,b,c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

^d NONE   (United States)

Author keywords

Cognition; Myelin; Neuropathology; Oligodendrocyte; Schizophrenia

Indexed keywords

MYELIN;

AGING; BRAIN REGION; COGNITION; CONCEPTUAL FRAMEWORK; DISEASE COURSE; GENOTYPE; HUMAN; MONKEY; MYELINATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL MODEL; REVIEW; SCHIZOPHRENIA; WHITE MATTER;

AGING; ANIMALS; APOLIPOPROTEINS E; COGNITION; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLORHINI; HUMANS; MODELS, NEUROLOGICAL; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIGNAL TRANSDUCTION;

EID: 34250897960     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707007638     Document Type: Review

References (226)

1. Aberg K, Saetre P, Jareborg N, Jazin E (2006a). Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proceedings of the National Academy of Sciences USA 103, 7482-7487.
2. Aberg K, Saetre P, Lindholm E, Ekholm B, Pettersson U, Adolfsson R, Jazin E (2006b). Human QKI, a new candidate gene for schizophrenia involved in myelination. American Journal of Medical Genetics, B: Neuropsychiatric Genetics 141, 84-90.
3. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H (2003). Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. Journal of Neuropathology and Experimental Neurology 62, 25-33.
4. Agartz I, Andersson JL, Skare S (2001). Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport 12, 2251-2254.
5. Ansari KA, Loch J (1975). Decreased myelin basic protein content of the aged human brain. Neurology 25, 1045-1050.
6. Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO (2003). MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport 14, 2025-2029.
7. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski JQ (1995). Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. American Journal of Psychiatry 152, 731-737.
8. Arnold SE, Lee VM, Gur RE, Trojanowski JQ (1991). Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proceedings of the National Academy of Sciences USA 88, 10850-10854.
9. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C (1998). Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Archives of General Psychiatry 55, 225-232.
10. Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC (2001). Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation. Schizophrenia Research 52, 87-99.
11. Bagary MS, Symms MR, Barker GJ, Mutsatsa SH, Joyce EM, Ron MA (2003). Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Archives of General Psychiatry 60, 779-788.
12. Barnett JH, Salmond CH, Jones PB, Sahakian BJ (2006). Cognitive reserve in neuropsychiatry. Psychological Medicine 36, 1053-1064.
13. Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RW (1999). A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biological Psychiatry 45, 1403-1411.
14. Bartzokis G (2002). Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation [see comment]. Neuropsychopharmacology 27, 672-683.
15. Bartzokis G (2004). Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiology of Aging 25, 5-18 (author reply, 49-62).
16. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL (2006). Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Archives of General Psychiatry 63, 63-72.
17. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL (2004). Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical 'disconnection' in aging and Alzheimer's disease. Neurobiology of Aging 25, 843-851.
18. Basser PJ, Jones DK (2002). Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR in Biomedicine 15, 456-467.
19. Basser PJ, Pierpaoli C (1996). Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. Journal of Magnetic Resonance, Series B 111, 209-219.
20. Beasley C, Dracheva S, Rosoklija G, Serafimova T, Mancevski B, Duma A, JJ M, WG H, Haroutunian V, Dwork AJ (in press). Myelin-associated proteins and mRNA in the cingulum bundle. International Congress on Schizophrenia Research, Colorado Springs, CO, 28 March-1 April, 2007.
21. Beaulieu C (2002). The basis of anisotropic water diffusion in the nervous system - a technical review. NMR in Biomedicine 15, 435-455.
22. Begre S, Federspiel A, Kiefer C, Schroth G, Dierks T, Strik WK (2003). Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport 14, 739-742.
23. Benes FM (1989). Myelination of cortical-hippocampal relays during late adolescence. Schizophrenia Bulletin 15, 585-593.
24. Benes FM (2004). A disturbance of late myelination as a trigger for Alzheimer's disease. Neurobiology of Aging 25, 41-43.
25. Benes FM, Turtle M, Khan Y, Farol P (1994). Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Archives of General Psychiatry 51, 477-484.
26. Berlet HH, Volk B (1980). Studies of human myelin proteins during old age. Mechanisms of Ageing and Development 14, 211-222.
27. Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, White III CL, Baker M, Hutton M (2001). Cortical synapse loss in progressive supranuclear palsy. Journal of Neuropathology and Experimental Neurology 60, 403-410.
28. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239-259.
29. Brambilla P, Cerini R, Gasparini A, Versace A, Andreone N, Vittorini E, Barbui C, Pelizza L, Nose M, Barlocco L, et al. (2005). Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophrenia Research 79, 201-210.
30. Bronge L (2002). Magnetic resonance imaging in dementia. A study of brain white matter changes. Acta Radiologica 428 (Suppl.), 1-32.
31. Brown FW, Lewine RJ, Hudgins PA, Risch SC (1992). White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. American Journal of Psychiatry 149, 620-625.
32. Brown FW, Lewine RR, Hudgins PA (1995). White matter hyperintensity signals associated with vascular risk factors in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19, 39-45.
33. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R (1993). Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biological Psychiatry 34, 529-535.
34. Buchsbaum MS, Friedman J, Buchsbaum BR, Chu KW, Hazlett EA, Newmark R, Schneiderman JS, Torosjan Y, Tang C, Hof PR, et al. (2006a). Diffusion tensor imaging in schizophrenia. Biological Psychiatry 60, 1181-1187.
35. Buchsbaum MS, Schoenknecht P, Torosjan Y, Newmark R, Chu KW, Mitelman S, Brickman AM, Shihabuddin L, Haznedar MM, Hazlett EA, et al. (2006b). Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Annals of General Psychiatry 5, 19.
36. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW (1998). MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9, 425-430.
37. Burns J, Job D, Bastin ME, Whalley H, Macgillivray T, Johnstone EC, Lawrie SM (2003). Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. British Journal of Psychiatry 182, 439-443.
38. Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, Purohit DP, Haroutunian V, Jones L (2002). Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. American Journal of Psychiatry 159, 59-65.
39. Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR (2003). Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry 160, 709-719.
40. Casanova MF, Zito M, Bigelow LB, Berthot B, Sanders RD, Kleinman JE (1989). Axonal counts of the corpus callosum of schizophrenic patients. Journal of Neuropsychiatry and Clinical Neurosciences 1, 391-393.
41. Chambers JS, Perrone-Bizzozero NI (2004). Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochemical Research 29, 2293-2302.
42. Chance SA, Highley JR, Esiri MM, Crow TJ (1999). Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. American Journal of Psychiatry 156, 1720-1724.
43. Charlton RA, Barrick TR, McIntyre DJ, Shen Y, O'Sullivan M, Howe FA, Clark CA, Morris RG, Markus HS (2006). White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 66, 217-222.
44. Chia LS, Thompson JE, Moscarello MA (1983). Changes in lipid phase behaviour in human myelin during maturation and aging. Involvement of lipid peroxidation. FEBS Letters 157, 155-158.
45. Chin SS, Goldman JE (1996). Glial inclusions in CNS degenerative diseases. Journal of Neuropathology and Experimental Neurology 55, 499-508.
46. Choe BY, Kim KT, Suh TS, Lee C, Paik IH, Bahk YW, Shinn KS, Lenkinski RE (1994). 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Academic Radiology 1, 211-216.
47. Coleman MP, Ribchester RR (2004). Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. Current Drug Targets - CNS & Neurological Disorders 3, 227-238.
48. 2+ exchanger. Proceedings of the National Academy of Sciences USA 101, 8168-8173.
49. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RS, Katz S, Frecska E (1995). Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. American Journal of Psychiatry 152, 197-207.
50. Davidsson P, Gottfries J, Bogdanovic N, Ekman R, Karlsson I, Gottfries CG, Blennow K (1999). The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophrenia Research 40, 23-29.
51. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry 60, 443-456.
52. Dawson DA, Hallenbeck JM (1996). Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. Journal of Cerebral Blood Flow and Metabolism 16, 170-174.
53. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM, Wardlaw JM (2006). White matter integrity and cognition in childhood and old age [see comment]. Neurology 66, 505-512.
54. DeKosky ST, Scheff SW (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Annals of Neurology 27, 457-464.
55. Dik M, Deeg DJ, Visser M, Jonker C (2003). Early life physical activity and cognition at old age. Journal of Clinical and Experimental Neuropsychology 25, 643-653.
56. Dorph-Petersen KA, Pierri JN, Sun Z, Sampson AR, Lewis DA (2004). Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. Journal of Comparative Neurology 472, 449-462.
57. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V (2006). Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 21, 531-540.
58. Dwork A, Ilievski B, Mancevski B, Kurzon M, Serafimova T, Trencevska I, Rosoklija G, Keilp J (2005). Histological evaluation of prefrontal white matter in schizophrenia. Society for Neuroscience Abstracts. Abstract no. 474.478.
59. Dwork AJ (1997). Postmortem studies of the hippocampal formation in schizophrenia. Schizophrenia Bulletin 23, 385-402.
60. Dwork AJ, Susser ES, Keilp J, Waniek C, Liu D, Kaufman M, Zemishlany Z, Prohovnik I (1998). Senile degeneration and cognitive impairment in chronic schizophrenia. American Journal of Psychiatry 155, 1536-1543.
61. Eastwood SL, Burnet PW, Harrison PJ (1995). Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66, 309-319.
62. Eastwood SL, Harrison PJ (1995). Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69, 339-343.
63. Eastwood SL, Harrison PJ (1999). Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 93, 99-106.
64. Falkai P, Honer WG, David S, Bogerts B, Majtenyi C, Bayer TA (1999). No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathology and Applied Neurobiology 25, 48-53.
65. Federspiel A, Begre S, Kiefer C, Schroth G, Strik WK, Dierks T (2006). Alterations of white matter connectivity in first episode schizophrenia. Neurobiology of Disease 22, 702-709.
66. Flechsig P (1920). Anatomie des menschlichen Gehirns und Rückenmarks auf myelogenetischer Grundlage. Leipzig: G. Thieme.
67. Flynn SW, Lang DJ, Mackay AL, Goghari V, Vavasour IM, Whittall KP, Smith GN, Arango V, Mann JJ, Dwork AJ, et al. (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and postmortem with analysis of oligodendrocyte proteins. Molecular Psychiatry 8, 811-820.
68. Foong J, Maier M, Barker GJ, Brocklehurst S, Miller DH, Ron MA (2000a). In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. Journal of Neurology, Neurosurgery and Psychiatry 68, 70-74.
69. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA (2000b). Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. Journal of Neurology, Neurosurgery and Psychiatry 68, 242-244.
70. Foong J, Symms MR, Barker GJ, Maier M, Miller DH, Ron MA (2002). Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport 13, 333-336.
71. Foong J, Symms MR, Barker GJ, Maier M, Woermann FG, Miller DH, Ron MA (2001). Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 124, 882-892.
72. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P (1997). Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Archives of General Psychiatry 54, 559-566.
73. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry 65, 446-453.
74. Glantz LA, Lewis DA (1997). Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of General Psychiatry 54, 943-952.
75. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry 57, 65-73.
76. Goldberg TE, Weinberger DR (1988). Probing prefrontal function in schizophrenia with neuropsychological paradigms. Schizophrenia Bulletin 14, 179-183.
77. Goto S, Hirano A (1990). Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism-dementia complex on Guam. Acta Neuropathologica 79, 545-550.
78. Graeber M, Blakemore W, Kreutzberg G (2002). Celllular pathology of the central nervous system. In: Graham D, Lantos P (Eds.), Greenfield's Neuropathology (pp. 123-191). New York: Arnold.
79. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, et al. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56, 301-307.
80. Grossman RI, Gomori JM, Ramer KN, Lexa FJ, Schnall MD (1994). Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics 14, 279-290.
81. Hachinski VC (1990). The decline and resurgence of vascular dementia. Canadian Medical Association Journal 142, 107-111.
82. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences USA 98, 4746-4751.
83. 1H-MR spectroscopy in the evaluation of epilepsies - what do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies? Acta Neurologica Scandinavica 108, 223-238.
84. Hamos JE, DeGennaro LJ, Drachman DA (1989). Synaptic loss in Alzheimer's disease and other dementias. Neurology 39, 355-361.
85. Hao J, Janssen WG, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, et al. (2003). Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. Journal of Comparative Neurology 465, 540-550.
86. Hao Y, Liu Z, Jiang T, Gong G, Liu H, Tan L, Kuang F, Xu L, Yi Y, Zhang Z (2006). White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport 17, 23-26.
87. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL (1994). Cortical cholinergic markers in schizophrenia. Schizophrenia Research 12, 137-144.
88. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624.
89. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence [Erratum appears in Molecular Psychiatry (2005) 10, 420]. Molecular Psychiatry 10, 40-68 (image 45).
90. Head D, Buckner RL, Shimony JS, Williams LE, Akbudak E, Conturo TE, McAvoy M, Morris JC, Snyder AZ (2004). Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cerebral Cortex 14, 410-423.
91. Heckers S (1997). Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophrenia Bulletin 23, 403-421.
92. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ (1999a). The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 122, 99-110.
93. Highley JR, Esiri MM, McDonald B, Roberts HC, Walker MA, Crow TJ (1999b). The size and fiber composition of the anterior commissure with respect to gender and schizophrenia. Biological Psychiatry 45, 1120-1127.
94. Highley JR, Walker MA, Esiri MM, Crow TJ, Harrison PJ (2002). Asymmetry of the uncinate fasciculus: a postmortem study of normal subjects and patients with schizophrenia. Cerebral Cortex 12, 1218-1224.
95. Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD (2002). Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochemical Research 27, 1193-1200.
96. Hof PR, Haroutunian V, Friedrich Jr. VL, Byne W, Buitron C, Perl DP, Davis KL (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biological Psychiatry 53, 1075-1085.
97. Honer WG, Dickson DW, Gleeson J, Davies P (1992). Regional synaptic pathology in Alzheimer's disease. Neurobiology of Aging 13, 375-382.
98. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, Hu L, Boulianne GL, Luo Z, Trimble WS (1997). Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 78, 99-110.
99. Honer WG, Young CE (2004). Presynaptic proteins and schizophrenia. International Review of Neurobiology 59, 175-199.
100. Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO (2004). DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport 15, 2467-2470.
101. Hoptman MJ, Volavka J, Johnson G, Weiss E, Bilder RM, Lim KO (2002). Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biological Psychiatry 52, 9-14.
102. Hubl D, Koenig T, Strik W, Federspiel A, Kreis R, Boesch C, Maier SE, Schroth G, Lovblad K, Dierks T (2004). Pathways that make voices: white matter changes in auditory hallucinations. Archives of General Psychiatry 61, 658-668.
103. Hulshoff Pol HE, Hoek HW, Susser E, Brown AS, Dingemans A, Schnack HG, van Haren NE, Pereira Ramos LM, Gispen-de Wied CC, Kahn RS (2000). Prenatal exposure to famine and brain morphology in schizophrenia. American Journal of Psychiatry 157, 1170-1172.
104. Hyde TM, Ziegler JC, Weinberger DR (1992). Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis [see comment]. Archives of Neurology 49, 401-406.
105. Ingvar DH, Risberg J, Schwartz MS (1975). Evidence of subnormal function of association cortex in presenile dementia. Neurology 25, 964-974.
106. Jones DK, Catani M, Pierpaoli C, Reeves SJ, Shergill SS, O'Sullivan M, Golesworthy P, McGuire P, Horsfield MA, Simmons A, et al. (2006). Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Human Brain Mapping 27, 230-238.
107. Jones DK, Symms MR, Cercignani M, Howard RJ (2005). The effect of filter size on VBM analyses of DT-MRI data. Neuroimage 26, 546-554.
108. Kaes T (1907). Die Grosshirnrinde des Menschen in ihern Massen und in ihrem Fasergehalt. Jena: Gustav Fisher.
109. Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, Nyffeler T, Buri C, Federspiel A, Kunz D, et al. (2006). Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage 30, 713-720.
110. Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E, Lehtimaki T (2004). Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. Journal of Human Genetics 49, 355-359.
111. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS (1999). Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Molecular Psychiatry 4, 39-45.
112. Kemper T (1994). Neuroanatomical and neuropathological changes during aging and dementia. In: Albert M, Knoefel J (Eds.), Clinical Neurology of Aging (pp. 3-67). New York: Oxford University Press.
113. Keshavan MS, Mulsant BH, Sweet RA, Pasternak R, Zubenko GS, Krishnan RR (1996). MRI changes in schizophrenia in late life : a preliminary controlled study. Psychiatry Research 60, 117-123.
114. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK (2006). Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiology of Disease 21, 626-632.
115. Kingsley PB, Monahan WG (2005). Contrast-to-noise ratios of diffusion anisotropy indices. Magnetic Resonance in Medicine 53, 911-918.
116. Kitamura H, Matsuzawa H, Shioiri T, Someya T, Kwee IL, Nakada T (2005). Diffusion tensor analysis in chronic schizophrenia. A preliminary study on a high-field (3.0T) system. European Archives of Psychiatry and Clinical Neuroscience 255, 313-318.
117. Klingberg T, Hedehus M, Temple E, Salz T, Gabrieli JD, Moseley ME, Poldrack RA (2000). Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from diffusion tensor magnetic resonance imaging. Neuron 25, 493-500.
118. Kubicki M, Park H, Westin CF, Nestor PG, Mulkern RV, Maier SE, Niznikiewicz M, Connor EE, Levitt JJ, Frumin M, et al. (2005). DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26, 1109-1118.
119. Kubicki M, Westin CF, Maier SE, Frumin M, Nestor PG, Salisbury DF, Kikinis R, Jolesz FA, McCarley RW, Shenton ME (2002). Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. American Journal of Psychiatry 159, 813-820.
120. Kubicki M, Westin CF, Nestor PG, Wible CG, Frumin M, Maier SE, Kikinis R, Jolesz FA, McCarley RW, Shenton ME (2003). Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biological Psychiatry 54, 1171-1180.
121. Kumra S, Ashtari M, McMeniman M, Vogel J, Augustin R, Becker DE, Nakayama E, Gyato K, Kane JM, Lim K, Szeszko P (2004). Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biological Psychiatry 55, 1138-1145.
122. Kuroki N, Kubicki M, Nestor PG, Salisbury DF, Park HJ, Levitt JJ, Woolston S, Frumin M, Niznikiewicz M, Westin CF, et al. (2006). Fornix integrity and hippocampal volume in male schizophrenic patients. Biological Psychiatry 60, 22-31.
123. Kursula P (2001). The current status of structural studies on proteins of the myelin sheath [Review]. International Journal of Molecular Medicine 8, 475-479.
124. Lamantia AS, Rakic P (1990). Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. Journal of Comparative Neurology 291, 520-537.
125. Lane B, Sullivan EV, Lim KO, Beal DM, Harvey Jr. RL, Meyers T, Faustman WO, Pfefferbaum A (1996). White matter MR hyperintensities in adult patients with congenital rubella. American Journal of Neuroradiology 17, 99-103.
126. Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ (2004). Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. American Journal of Psychiatry 161, 1848-1855.
127. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A (1998). Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Archives of General Psychiatry 55, 346-352.
128. Lim KO, Ardekani BA, Nierenberg J, Butler PD, Javitt DC, Hoptman MJ (2006). Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. American Journal of Psychiatry 163, 2008-2010.
129. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999). Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Archives of General Psychiatry 56, 367-374.
130. Lintl P, Braak H (1983). Loss of intracortical myelinated fibers: a distinctive age-related alteration in the human striate area. Acta Neuropathologica 61, 178-182.
131. Liston C, Watts R, Tottenham N, Davidson MC, Niogi S, Ulug AM, Casey BJ (2006). Frontostriatal microstructure modulates efficient recruitment of cognitive control. Cerebral Cortex 16, 553-560.
132. Mancevski B, Ilievski B, Trencevska I, Serafimova T, Rosoklija G, Keilp J, Dwork A (2006). Myelin and cognition in schizophrenia. Society for Neuroscience Abstracts. Abstract no. 20.26.
133. Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003). Marked loss of myelinated nerve fibers in the human brain with age. Journal of Comparative Neurology 462, 144-152.
134. Marner L, Pakkenberg B (2003). Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics. Journal of Psychiatric Research 37, 539-547.
135. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA (1991). Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. American Journal of Pathology 138, 235-246.
136. Masliah E, Terry RD, DeTeresa RM, Hansen LA (1989). Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neuroscience Letters 103, 234-239.
137. McCullumsmith R, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis K, Meador-Woodruff J (2007). Expression of transcripts for myelin-associated genes in the anterior cingulate cortex in schizophrenia. Schizophrenia Research 90, 15-27.
138. Meier-Ruge W, Ulrich J, Bruhlmann M, Meier E (1992). Age-related white matter atrophy in the human brain. Annals of the New York Academy of Sciences 673, 260-269.
139. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004). Axonal neuregulin-1 regulates myelin sheath thickness [see comment]. Science 304, 700-703.
140. Miller AK, Alston RL, Corsellis JA (1980). Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathology and Applied Neurobiology 6, 119-132.
141. Minami T, Nobuhara K, Okugawa G, Takase K, Yoshida T, Sawada S, Ha-Kawa S, Ikeda K, Kinoshita T (2003). Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology 47, 141-145.
142. Miyakawa T, Sumiyoshi S, Deshimaru M, Suzuki T, Tomonari H (1972). Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathologica 20, 67-77.
143. Morriss MC, Zimmerman RA, Bilaniuk LT, Hunter JV, Haselgrove JC (1999). Changes in brain water diffusion during childhood. Neuroradiology 41, 929-934.
144. Nagy Z, Westerberg H, Klingberg T (2004). Maturation of white matter is associated with the development of cognitive functions during childhood. Journal of Cognitive Neuroscience 16, 1227-1233.
145. Nasrallah HA, McCalley-Whitters M, Bigelow LB, Rauscher FP (1983). A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Research 8, 251-260.
146. Nebes RD, Meltzer CC, Whyte EM, Scanlon JM, Halligan EM, Saxton JA, Houck PR, Boada FE, Dekosky ST (2006). The relation of white matter hyperintensities to cognitive performance in the normal old: education matters. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition 13, 326-340.
147. Nestor PG, Kubicki M, Gurrera RJ, Niznikiewicz M, Frumin M, McCarley RW, Shenton ME (2004). Neuropsychological correlates of diffusion tensor imaging in schizophrenia. Neuropsychology 18, 629-637.
148. Nielsen K, Peters A (2000). The effects of aging on the frequency of nerve fibers in rhesus monkey striate cortex. Neurobiology of Aging 21, 621-628.
149. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO (2005). Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport 16, 1369-1372.
150. Okugawa G, Nobuhara K, Minami T, Tamagaki C, Takase K, Sugimoto T, Sawada S, Kinoshita T (2004). Subtle disruption of the middle cerebellar peduncles in patients with schizophrenia. Neuropsychobiology 50, 119-123.
151. Okugawa G, Nobuhara K, Sugimoto T, Kinoshita T (2005). Diffusion tensor imaging study of the middle cerebellar peduncles in patients with schizophrenia. Cerebellum 4, 123-127.
152. Ortakov V, Mancevski B, Keilp J, Oppenheim S, Dwork AJ (1999). Application of cognitive scales to medical records of schizophrenia inpatients. Schizophrenia Research 35, 131-140.
153. Ota M, Obata T, Akine Y, Ito H, Ikehira H, Asada T, Suhara T (2006). Age-related degeneration of corpus callosum measured with diffusion tensor imaging. Neuroimage 31, 1445-1452.
154. Pakkenberg B (1992). Stereological quantitation of human brains from normal and schizophrenic individuals. Acta Neurologica Scandinavica 137 (Suppl.), 20-33.
155. Pakkenberg B, Pelvig D, Marner L, Bundgaard MJ, Gundersen HJ, Nyengaard JR, Regeur L (2003). Aging and the human neocortex. Experimental Gerontology 38, 95-99.
156. Park HJ, Westin CF, Kubicki M, Maier SE, Niznikiewicz M, Baer A, Frumin M, Kikinis R, Jolesz FA, McCarley RW, Shenton ME (2004). White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study. Neuroimage 23, 213-223.
157. Peirce TR, Bray NJ, Williams NM, Norton N, Moskvina V, Preece A, Haroutunian V, Buxbaum JD, Owen MJ, O'Donovan MC (2006). Convergent evidence for 2′,3′-cyclic nucleotide 3′-phosphodiesterase as a possible susceptibility gene for schizophrenia. Archives of General Psychiatry 63, 18-24.
158. Perdahl E, Adolfsson R, Alafuzoff I, Albert KA, Nestler EJ, Greengard P, Winblad B (1984). Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia. Journal of Neural Transmission 60, 133-141.
159. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL (1996). Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proceedings of the National Academy of Sciences USA 93, 14182-14187.
160. Persson J, Lind J, Larsson A, Ingvar M, Cruts M, Van Broeckhoven C, Adolfsson R, Nilsson LG, Nyberg L (2006a). Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 66, 1029-1033.
161. Persson J, Nyberg L, Lind J, Larsson A, Nilsson LG, Ingvar M, Buckner RL (2006b). Structure-function correlates of cognitive decline in aging. Cerebral Cortex 16, 907-915.
162. Peters A (1996). Age-related changes in oligodendrocytes in monkey cerebral cortex. Journal of Comparative Neurology 371, 153-163.
163. Peters A, Josephson K, Vincent SL (1991). Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex. Anatomical Record 229, 384-398.
164. Peters A, Moss MB, Sethares C (2000). Effects of aging on myelinated nerve fibers in monkey primary visual cortex. Journal of Comparative Neurology 419, 364-376.
165. Peters A, Sethares C (2002). Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. Journal of Comparative Neurology 442, 277-291.
166. Peters A, Sethares C (2003). Is there remyelination during aging of the primate central nervous system? Journal of Comparative Neurology 460, 238-254.
167. Peters A, Sethares C (2004). Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cerebral Cortex 14, 995-1007.
168. Pfefferbaum A, Adalsteinsson E, Sullivan EV (2005). Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 26, 891-899.
169. Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix LR, Virta A, Basser P (2001). Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage 13, 1174-1185.
170. Pierpaoli C, Basser PJ (1996). Toward a quantitative assessment of diffusion anisotropy. Magnetic Resonance in Medicine 36, 893-906.
171. Price G, Bagary MS, Cercignani M, Altmann DR, Ron MA (2005). The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. Journal of Neurology, Neurosurgery and Psychiatry 76, 585-587.
172. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL (1998). Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Archives of General Psychiatry 55, 205-211.
173. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B (1994). No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiology of Aging 15, 347-352.
174. Rivkin P, Kraut M, Barta P, Anthony J, Arria AM, Pearlson G (2000). White matter hyperintensity volume in late-onset and early-onset schizophrenia. International Journal of Geriatric Psychiatry 15, 1085-1089.
175. Rosoklija G, Keilp JG, Toomayan G, Mancevski B, Haroutunian V, Liu D, Malespina D, Hays AP, Sadiq S, Latov N, Dwork AJ (2005). Altered Subicular MAP2 Immunoreactivity in Schizophrenia. Prilozi 26, 13-34.
176. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP, Dwork AJ (2000). Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Archives of General Psychiatry 57, 349-356.
177. Salat DH, Tuch DS, Greve DN, van der Kouwe AJ, Hevelone ND, Zaleta AK, Rosen BR, Fischl B, Corkin S, Rosas HD, Dale AM (2005). Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiology of Aging 26, 1215-1227.
178. Sandell JH, Peters A (2002). Effects of age on the glial cells in the rhesus monkey optic nerve. Journal of Comparative Neurology 445, 13-28.
179. Sandell JH, Peters A (2003). Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. Journal of Comparative Neurology 466, 14-30.
180. Savitz J, Solms M, Ramesar R (2006). Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Research. Brain Research Reviews 51, 125-135.
181. Scarmeas N, Habeck CG, Hilton J, Anderson KE, Flynn J, Park A, Stern Y (2005). APOE related alterations in cerebral activation even at college age. Journal of Neurology, Neurosurgery and Psychiatry 76, 1440-1444.
182. Schachner M, Bartsch U (2000). Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29, 154-165.
183. Schmithorst VJ, Wilke M, Dardzinski BJ, Holland SK (2005). Cognitive functions correlate with white matter architecture in a normal pediatric population: a diffusion tensor MRI study. Human Brain Mapping 26, 139-147.
184. Schneiderman J, Buchsbaum M, Haznedar M, Hazlett E, Brickman A, Shihabuddin L, Brand J, Torosjan Y, Newmark R, Tang C, et al. (in press). Diffusion tensor anisotropy in adolescents and adults. Neurospsychobiology.
185. Schneiderman JS, Buchsbaum M, Haznedar M, Hazlett EA, Shihabuddin L, Brand J, Brickman AM, Torosjan Y, Newmark RE, Tang C, Aranowitz J, Paul-Odougard R (2006). Age and diffusion tensor anisotropy in adolescent and adult patients with schizophrenia. Society for Neuroscience Abstracts. Abstract no. 188.186.
186. Shenkin SD, Bastin ME,Macgillivray TJ, Deary IJ, Starr JM, Rivers CS, Wardlaw JM (2005). Cognitive correlates of cerebral white matter lesions and water diffusion tensor parameters in community-dwelling older people. Cerebrovascular Diseases 20, 310-318.
187. Shenkin SD, Bastin ME, MacGillivray TJ, Deary IJ, Starr JM, Wardlaw JM (2003). Childhood and current cognitive function in healthy 80-year-olds: a DT-MRI study. Neuroreport 14, 345-349.
188. Sloane JA, Hinman JD, Lubonia M, Hollander W, Abraham CR (2003). Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey. Journal of Neurochemistry 84, 157-168.
189. Song SK, Kim JH, Lin SJ, Brendza RP, Holtzman DM (2004). Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiology of Disease 15, 640-647.
190. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH (2003). Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20, 1714-1722.
191. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002). Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17, 1429-1436.
192. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, Armstrong RC (2005). Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26, 132-140.
193. Steel RM, Bastin ME, McConnell S, Marshall I, Cunningham-Owens DG, Lawrie SM, Johnstone EC, Best JJ (2001). Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Research 106, 161-170.
194. Stern RA, Silva SG, Chaisson N, Evans DL (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Archives of Neurology 53, 148-153.
195. Stern Y (2006). Cognitive reserve and Alzheimer disease. Alzheimer Disease and Associated Disorders 20, 112-117.
196. Sullivan EV, Pfefferbaum A (2003). Diffusion tensor imaging in normal aging and neuropsychiatric disorders. European Journal of Radiology 45, 244-255.
197. Sun SW, Liang HF, Le TQ, Armstrong RC, Cross AH, Song SK (2006a). Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 32, 1195-1204.
198. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK (2006b). Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magnetic Resonance in Medicine 55, 302-308.
199. Sun SW, Song SK, Harms MP, Lin SJ, Holtzman DM, Merchant KM, Kotyk JJ (2005). Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Experimental Neurology 191, 77-85.
200. Sun Z, Wang F, Cui L, Breeze J, Du X, Wang X, Cong Z, Zhang H, Li B, Hong N, Zhang D (2003). Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study. Neuroreport 14, 1833-1836.
201. Suzuki Y, Matsuzawa H, Kwee IL, Nakada T (2003). Absolute eigenvalue diffusion tensor analysis for human brain maturation. NMR in Biomedicine 16, 257-260.
202. Svennerholm L, Bostrom K, Helander CG, Jungbjer B (1991). Membrane lipids in the aging human brain. Journal of Neurochemistry 56, 2051-2059.
203. Svennerholm L, Bostrom K, Jungbjer B (1997). Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathologica 94, 345-352.
204. Symonds LL, Olichney JM, Jernigan TL, Corey-Bloom J, Healy JF, Jeste DV (1997). Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. Journal of Neuropsychiatry and Clinical Neurosciences 9, 251-258.
205. Szeszko PR, Ardekani BA, Ashtari M, Kumra S, Robinson DG, Sevy S, Gunduz-Bruce H, Malhotra AK, Kane JM, Bilder RM, Lim KO (2005). White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. American Journal of Psychiatry 162, 602-605.
206. Tang Y, Nyengaard JR, Pakkenberg B, Gundersen HJ (1997). Age-induced white matter changes in the human brain: a stereological investigation. Neurobiology of Aging 18, 609-615.
207. Tcherepanov AA, Sokolov BP (1997). Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. Journal of Neuroscience Research 49, 639-644.
208. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30, 572-580.
209. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805.
210. Toosy AT, Werring DJ, Orrell RW, Howard RS, King MD, Barker GJ, Miller DH, Thompson AJ (2003). Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 74, 1250-1257.
211. Tyszka JM, Readhead C, Bearer EL, Pautler RG, Jacobs RE (2006). Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. Neuroimage 29, 1058-1065.
212. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V (2001). Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin 55, 597-610.
213. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269-275.
214. Vawter MP, Howard AL, Hyde TM, Kleinman JE, Freed WJ (1999). Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Molecular Psychiatry 4, 467-475.
215. Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, Dassori A, Leach RJ, Almasy L, Escamilla M, Raventos H (2006). A novel missense mutation in the transmembrane domain of Neuregulin 1 is associated with schizophrenia. Biological Psychiatry 60, 548-553.
216. Walterfang M, Wood SJ, Velakoulis D, Pantelis C (2006). Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neuroscience and Biobehavioral Reviews 30, 918-948.
217. Wang DS, Bennett DA, Mufson EJ, Mattila P, Cochran E, Dickson DW (2004a). Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neuroscience Research 48, 93-100.
218. Wang F, Sun Z, Cui L, Du X, Wang X, Zhang H, Cong Z, Hong N, Zhang D (2004b). Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. American Journal of Psychiatry 161, 573-575.
219. Wang F, Sun Z, Du X, Wang X, Cong Z, Zhang H, Zhang D, Hong N (2003). A diffusion tensor imaging study of middle and superior cerebellar peduncle in male patients with schizophrenia. Neuroscience Letters 348, 135-138.
220. Weinberger DR, Berman KF, Zec RF (1986). Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Archives of General Psychiatry 43, 114-124.
221. Wender M, Adamczewska-Goncerzewicz Z, Dorszewska J (1991). Myelin proteins in aging human brain. Molecular and Chemical Neuropathology 14, 1-10.
222. Wiggins RC, Gorman A, Rolsten C, Samorajski T, Ballinger Jr. WE, Freund G (1988). Effects of aging and alcohol on the biochemical composition of histologically normal human brain. Metabolic Brain Disease 3, 67-80.
223. Wolkin A, Choi SJ, Szilagyi S, Sanfilipo M, Rotrosen JP, Lim KO (2003). Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. American Journal of Psychiatry 160, 572-574.
224. Wu JI, Reed RB, Grabowski PJ, Artzt K (2002). Function of quaking in myelination: regulation of alternative splicing. Proceedings of the National Academy of Sciences USA 99, 4233-4238.
225. Yakovlev P, Lecours A (1967). The myelogenetic cycles of regional maturation of the brain. In: Minowski, A (Ed.), Regional Development of the Brain in Early Life (pp. 3-70). Philadelphia: F.A. Davis.
226. Young KA, Manaye KF, Liang C, Hicks PB, German DC (2000). Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biological Psychiatry 47, 944-953.